Skip to Main Content

Paper Details

Molecular, Pathological, Radiological, and Immune Profiling of Non-brainstem Pediatric High-Grade Glioma from the HERBY Phase II Randomized Trial.
Cancer Cell
133
2018
BEV, BRAF_V600E, CD8+, CD8+ tumor-infiltrating lymphocytes, HGG, Histone H3, NF1, NF1 mutation, Non-brainstem Pediatric High-Grade Glioma, POLD1, POLE, PXA, bevacizumab, high-grade glioma, hypermutator tumors, mismatch repair deficiency, non, patients, pleomorphic xanthoastrocytoma, temozolomide, tumor
Author NameAffiliation
Alan MackayThe Institute of Cancer Research
Anna BurfordThe Institute of Cancer Research
Valeria MolinariThe Institute of Cancer Research
David T W JonesHopp Children's Cancer Center at the NCT Heidelberg (KiTZ), German Cancer Research Center (DKFZ)
David T W JonesHopp Children's Cancer Center at the NCT Heidelberg (KiTZ), German Cancer Research Center (DKFZ)
Elisa IzquierdoThe Institute of Cancer Research
Jurriaan Brouwer-Visser
Felice GiangasperoSapienza University, Italy IRCCS Neuromed
Christine HaberlerInstitute of Neurology, Medical University of Vienna, Austria Comprehensive Cancer Center
Torsten PietschInstitute of Neuropathology, University of Bonn Medical Center
Thomas S JacquesUCL Great Ormond Street Institute of Child Health, Great Ormond Street Hospital for Children
Dominique Figarella-BrangerLa Timone Hospital, Aix Marseille University
Daniel RodriguezNottingham University Hospitals
Paul S MorganNottingham University Hospitals
Pichai RamanThe Center for Data Driven Discovery in Biomedicine (D(3)b), Children's Hospital of Philadelphia
Pichai RamanThe Center for Data Driven Discovery in Biomedicine (D(3)b), Children's Hospital of Philadelphia
Angela J WaandersThe Center for Data Driven Discovery in Biomedicine (D(3)b), Children's Hospital of Philadelphia
Angela J WaandersThe Center for Data Driven Discovery in Biomedicine (D(3)b), Children's Hospital of Philadelphia
Adam C ResnickThe Center for Data Driven Discovery in Biomedicine (D(3)b), Children's Hospital of Philadelphia
Adam C ResnickThe Center for Data Driven Discovery in Biomedicine (D(3)b), Children's Hospital of Philadelphia
Maura MassiminoFondazione IRCCS, Istituto Nazionale Tumori
Maura MassiminoFondazione IRCCS, Istituto Nazionale Tumori
Maria Luisa Garr??Istituto Giannina Gaslini
Maria Luisa Garr??Istituto Giannina Gaslini
Helen SmithF. Hoffmann-La Roche Ltd
David CapperCharite - Universitatsmedizin Berlin, Corporate Member of Freie Universitat Berlin, Humboldt-Universitat zu Berlin, Germany Berlin Institute of Health, Institute of Neuropathology, University Hospital Heidelberg and Clinical Cooperation Unit Neuropathology, German Cancer Research Center (DKFZ)
David CapperCharite - Universitatsmedizin Berlin, Corporate Member of Freie Universitat Berlin, Humboldt-Universitat zu Berlin, Germany Berlin Institute of Health, Institute of Neuropathology, University Hospital Heidelberg and Clinical Cooperation Unit Neuropathology, German Cancer Research Center (DKFZ)
Stefan M PfisterHopp Children's Cancer Center at the NCT Heidelberg (KiTZ), German Cancer Research Center (DKFZ), Heidelberg University Hospital
Stefan M PfisterHopp Children's Cancer Center at the NCT Heidelberg (KiTZ), German Cancer Research Center (DKFZ), Heidelberg University Hospital
Thomas WurdingerVU Medical Center
Rachel Tam
Josep GarciaF. Hoffmann-La Roche Ltd
Meghna Das Thakur
Gilles VassalParis-Saclay University
Jacques GrillParis-Saclay University
Tim JaspanNottingham University Hospitals
Pascale VarletSainte-Anne Hospital, Paris-Descartes University
Pascale VarletSainte-Anne Hospital, Paris-Descartes University
Chris JonesThe Institute of Cancer Research
  • 1 - 39

Datasets